Loren Data's SAM Daily™

SAMDAILY.US - ISSUE OF JULY 14, 2022 SAM #7531
SPECIAL NOTICE

A -- Luminex Corporation ARIES SARS-CoV-2 FDA 510(k) Clearance

Notice Date

7/12/2022 10:50:52 AM
 

Notice Type

Special Notice
 

NAICS

541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
 

Contracting Office

BARDA - ASPR / DAAPPO / BARDA DCMA WASHINGTON DC 20515 USA
 

ZIP Code

20515
 

Solicitation Number

BARDA-06362022
 

Response Due

7/27/2022 11:00:00 AM
 

Point of Contact

Davis Perkins, Amber Gray
 

E-Mail Address

davis.perkins@hhs.gov, amber.gray@hhs.gov
(davis.perkins@hhs.gov, amber.gray@hhs.gov)
 

Description

This is a notice of intent to sole source to Luminex Corporation for�the required clinical and development work to obtain U.S. Food and Drug Administration (FDA) Section 510(k) clearance of Luminex Corporation�s combined ARIES � Flu A/B/RSV + Coronavirus (SARS-CoV-2 test using simplified acquisition procedures. FDA 510(k) clearance will allow Luminex to commercially market their combined SARS-CoV-2, influenza A, influenza B, and Respiratory syncytial virus (RSV) diagnostic test that operate on the proprietary ARIES� platform.� Interested vendors should contact the POCs listed in this notice prior to July 27, 2022 at 2:00pm Eastern.
 

Web Link

SAM.gov Permalink
(https://sam.gov/opp/a8a488d4aa2b4376bc6dcad107493eef/view)
 

Place of Performance

Address: Austin, TX 78727, USA

Zip Code: 78727

Country: USA
 

Record

SN06385323-F 20220714/220712230100 (samdaily.us)
 

Source

SAM.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |